Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPITOC: Platinum-based vs Non-platinum Chemotherapy in Platinum-resistant Ovarian Cancer
NCT04055038Phase 3Unknown
- Sponsor
- N.N. Blokhin Russian Cancer Research Center
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, cisplatin in ovarian cancer, sponsored by N.N. Blokhin Russian Cancer Research Center. Status: unknown.
02
Drugs
carboplatincisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04055038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04055038.